John Quinn is a distinguished scientist in biochemical and cellular pharmacology at Genentech since February 2015, where contributions focus on drug discovery. Prior to this, John served as the principal scientist in biophysical chemistry at Takeda San Diego, leading biophysical characterization and the implementation of real-time biosensing in therapeutic development from December 2012 to February 2015. John's earlier experience includes tenure as the chief scientific officer at ICx Technologies, where JOHN originated the biosensor product line from June 2005 to November 2012, and as a senior scientist in the SPREETA Development Group at Texas Instruments from 2000 to 2005. John Quinn earned a PhD in Applied Biochemistry and Immunology from Dublin City University.
This person is not in any teams
This person is not in any offices